Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Never miss an Options trading signal: Unusual Options Activity and Options Screeners with Barchart Premier. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Stryker Corp (SYK)

Stryker Corp (SYK)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Market News and Commentary

A Decade From Now, You'll Regret Not Buying This 1 Small-Cap Stock

Small-cap stocks rarely receive the limelight they deserve. A handful of small-cap companies are quietly laying the groundwork for long-term success. They are expanding market share, improving profitability, and scaling their business models while most investors ignore them for the short-term volatility.

With a market cap of $2.07 billion, Alphatec Holdings (ATEC) is one such small-cap stock that investors may regret not buying 10 years from now.

Fundamentals

See More
  • Market Capitalization, $K 148,276,672
  • Shares Outstanding, K 382,689
  • Annual Sales, $ 25,116 M
  • Annual Income, $ 3,246 M
  • EBIT $ 5,621 M
  • EBITDA $ 6,814 M
  • 60-Month Beta 0.87
  • Price/Sales 5.90
  • Price/Cash Flow 22.85
  • Price/Book 6.59

Options Overview Details

View History
  • Implied Volatility 22.12% (+0.32%)
  • Historical Volatility 19.85%
  • IV Percentile 39%
  • IV Rank 15.25%
  • IV High 47.93% on 04/08/25
  • IV Low 17.47% on 08/12/25
  • Expected Move (DTE 19) 13.95 (3.60%)
  • Put/Call Vol Ratio 1.28
  • Today's Volume 164
  • Volume Avg (30-Day) 1,118
  • Put/Call OI Ratio 0.71
  • Today's Open Interest 23,347
  • Open Int (30-Day) 27,082
  • Expected Range 373.51 to 401.41

Analyst Rating / Earnings Estimates

Current Rating
See More
Moderate Buy
Based on 28 analysts offering recommendations.
Earnings Estimates - Current Qtr 03/31/26
See More
  • Average Estimate 3.00
  • Number of Estimates 11
  • High Estimate 3.18
  • Low Estimate 2.92
  • Prior Year 2.84
  • Growth Rate Est. (year over year) +5.63%

Price Performance

See More
Period Period Low Period High Performance
1-Month
349.37 +10.90%
on 02/09/26
388.67 -0.31%
on 02/27/26
+32.89 (+9.28%)
since 01/27/26
3-Month
344.63 +12.43%
on 01/05/26
388.67 -0.31%
on 02/27/26
+15.17 (+4.07%)
since 11/26/25
52-Week
329.16 +17.71%
on 04/07/25
404.87 -4.30%
on 07/23/25
-1.44 (-0.37%)
since 02/27/25

Most Recent Stories

More News
A Decade From Now, You'll Regret Not Buying This 1 Small-Cap Stock

The best long-term winners often start small.

SYK : 387.46 (+0.36%)
$SPX : 6,878.88 (-0.43%)
JNJ : 248.43 (+2.04%)
MDT : 97.66 (+0.65%)
ISRG : 503.51 (-0.66%)
ATEC : 13.62 (-2.78%)
How Is Stryker's Stock Performance Compared to Other Healthcare Stocks?

Despite Stryker’s underperformance relative to its peers over the past year, Wall Street analysts remain moderately optimistic about the stock’s prospects.

XLV : 160.20 (+1.77%)
SYK : 387.46 (+0.36%)
BDX : 176.48 (-0.10%)
1 Profitable Stock to Keep an Eye On and 2 We Turn Down

1 Profitable Stock to Keep an Eye On and 2 We Turn Down

SYK : 387.46 (+0.36%)
DBD : 80.00 (-3.67%)
STNG : 79.08 (+2.69%)
Stryker launches Synchfix™ EVT, expanding options for flexible syndesmotic fixation

Elevating care with Stryker's next generation device, Synchfix EVT , which will be featured at the 2026 American College of Foot and Ankle Surgeons (ACFAS) Annual Meeting

SYK : 387.46 (+0.36%)
Are Wall Street Analysts Bullish on Stryker Stock?

Stryker has underperformed the broader market over the past year, but analysts are moderately optimistic about the stock’s prospects.

SYK : 387.46 (+0.36%)
$SPX : 6,878.88 (-0.43%)
MS : 166.51 (-6.19%)
IHI : 60.20 (-0.20%)
Stryker launches T2 Alpha Humerus Nailing System, supporting surgical workflow and care for complex fractures

PORTAGE, Mich. , Feb. 11, 2026 /PRNewswire/ -- Stryker (NYSE: SYK), a global leader in medical technologies, announced the launch of the T2 Alpha Humerus Nailing System, the latest addition to its...

SYK : 387.46 (+0.36%)
Stryker introduces Mako Handheld Robotics with the limited market release of Mako RPS

PORTAGE, Mich. , Feb. 9, 2026 /PRNewswire/ -- Stryker (NYSE: SYK), a global leader in medical technologies, announced the limited market release of Mako RPS (Robotic Power System) for Total Knee,...

SYK : 387.46 (+0.36%)
Stryker declares an $0.88 per share quarterly dividend

Portage, Michigan, Feb. 04, 2026 (GLOBE NEWSWIRE) -- Stryker (NYSE:SYK) announced that its Board of Directors has declared a quarterly dividend of $0.88 per share payable April 30, 2026, to shareholders...

SYK : 387.46 (+0.36%)
1 Safe-and-Steady Stock with Competitive Advantages and 2 Facing Challenges

1 Safe-and-Steady Stock with Competitive Advantages and 2 Facing Challenges

TMHC : 65.89 (+0.12%)
SYK : 387.46 (+0.36%)
GILD : 148.95 (+3.60%)
Stryker’s (NYSE:SYK) Q4 CY2025 Sales Top Estimates

Stryker’s (NYSE:SYK) Q4 CY2025 Sales Top Estimates

SYK : 387.46 (+0.36%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 24% Buy with a Average short term outlook on maintaining the current direction.

See More Share

Business Summary

Stryker Corporation is a medical device company operating in the global orthopedic market. The company has three business segments: Orthopaedics, MedSurg and Neurotechnology & Spine. Orthopaedic'products include implants used in hip and knee joint replacements and trauma and extremities surgeries. MedSurg'products...

See More

Key Turning Points

3rd Resistance Point 397.09
2nd Resistance Point 392.88
1st Resistance Point 390.17
Last Price 387.46
1st Support Level 383.25
2nd Support Level 379.04
3rd Support Level 376.33

See More

52-Week High 404.87
Last Price 387.46
Fibonacci 61.8% 375.95
Fibonacci 50% 367.02
Fibonacci 38.2% 358.08
52-Week Low 329.16

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar